AR and cancer: On the other hand, hormonal therapy-resistant cancer shows abrupt signaling where over 50% of cases are linked with molecular and cellular change altering the activation of androgen receptors and cancer cells proliferation even at low serum testosterone levels [63,64,65,66,67,68,69,70,71].